The Takeaway In addition to the reminder that its a great time to be a GLP-1 biotech, Roches acquisition of Carmot Therapeutics is another sign that were still in the early innings of the GLP-1 ballgame
A team of researchers developed a nanostructure-based GLP-1R agonist capable of crossing the BBB that significantly attenuated neuroinflammation and memory loss in an A peptide-induced mouse model of AD by inhibiting the inflammatory responses of microglia and astrocytes (Zhao et al., 2022)
These symptoms often disrupt daily life and occur in the two weeks before menstruation
A supplementary search also identified Atila et al
A dull needle can cause tissue damage and bruising, making the injection process more traumatic for the user
J Appl Physiol 86:479487 (Bethesda, Md.: 1985) Gollnick PD, Karlsson J, Piehl K, Saltin B (1974) Selective glycogen depletion in skeletal muscle fibres of man following sustained contractions